Skip to main content
. 2022 Jul 26;26:100520. doi: 10.1016/j.lanwpc.2022.100520

Table 2.

Disability weights with 95% UI for 206 health states in mainland China.

Disability weight (95% UI)
Infectious disease
1  Acute episode, mild 0·027 (0·002-0·113)
2  Acute episode, moderate 0·137 (0·054-0·273)
3  Acute episode, severe 0·152 (0·066-0·288)
4  Post-acute consequences (fatigue, emotional lability, and insomnia) 0·080 (0·020-0·210)
Diarrhoea
5  Mild 0·072 (0·016-0·198)
6  Moderate 0·151 (0·064-0·286)
7  Severe 0·259 (0·170-0·368)
8 Epididymo-orchitis 0·122 (0·044-0·259)
9 Herpes zoster 0·045 (0·006-0·154)
10 HIV: symptomatic, pre-AIDS 0·252 (0·163-0·363)
11 HIV/AIDS: receiving antiretroviral (ARV) treatment 0·074 (0·017-0·201)
12 AIDS: not receiving antiretroviral (ARV) treatment 0·367 (0·309-0·432)
13 Intestinal nematode infections: symptomatic 0·112 (0·037-0·248)
14 Lymphatic filariasis: symptomatic 0·153 (0·067-0·289)
15 Ear pain 0·052 (0·009-0·166)
Tuberculosis
16  Not HIV infected 0·375 (0·319-0·435)
17  HIV infected 0·297 (0·216-0·390)
Cancer
18  Diagnosis and primary treatment 0·264 (0·176-0·371)
19  Metastatic 0·324 (0·251-0·407)
Terminal phase
20  With medication (for cancers and end-stage kidney or liver disease) 0·515 (0·505-0·527)
21  Without medication (for cancers and end-stage kidney or liver disease) 0·411 (0·369-0·454)
Cardiovascular and circulatory disease
Acute myocardial infarction
22  Days 1–2 0·261 (0·173-0·368)
23  Days 3–28 0·075 (0·018-0·202)
Angina pectoris
24  Mild 0·037 (0·004-0·135)
25  Moderate 0·055 (0·010-0·173)
26  Severe 0·163 (0·074-0·297)
27 Cardiac conduction disorders and cardiac dysrhythmias 0·256 (0·165-0·364)
28 Claudication 0·021 (0·001-0·095)
Heart failure
29  Mild 0·057 (0·010-0·175)
30  Moderate 0·089 (0·024-0·221)
31  Severe 0·162 (0·073-0·295)
Stroke
32  Long-term consequences, mild 0·053 (0·009-0·169)
33  Long-term consequences, moderate 0·057 (0·010-0·175)
34  Long-term consequences, moderate plus cognition problems 0·111 (0·036-0·247)
35  Long-term consequences, severe 0·355 (0·290-0·423)
36  Long-term consequences, severe plus cognition problems 0·400 (0·353-0·449)
Diabetes and digestive and genitourinary disease
37 Diabetic neuropathy 0·094 (0·027-0·227)
38 Chronic kidney disease (stage IV) 0·080 (0·020-0·210)
39  With kidney transplantation 0·071 (0·016-0·197)
40  On dialysis 0·672 (0·594-0·745)
41 Decompensated cirrhosis of the liver 0·108 (0·035-0·244)
42 Gastric bleeding 0·390 (0·338-0·443)
43 Crohn's disease or ulcerative colitis 0·135 (0·053-0·271)
44 Benign prostatic hypertrophy: symptomatic 0·088 (0·023-0·221)
45 Urinary incontinence 0·234 (0·143-0·351)
46 Stress incontinence 0·044 (0·006-0·151)
47 Impotence 0·058 (0·011-0·177)
Infertility
48  Primary 0·026 (0·002-0·111)
49  Secondary 0·018 (0·001-0·088)
50 Often has a burning sensation in the back of the chest after eating 0·088 (0·024-0·219)
Chronic respiratory disease
Asthma
51  Controlled 0·032 (0·003-0·126)
52  Partially controlled 0·081 (0·020-0·211)
53  Uncontrolled 0·227 (0·136-0·346)
Chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases
54  Mild 0·022 (0·002-0·101)
55  Moderate 0·176 (0·086-0·308)
56  Severe 0·284 (0·200-0·383)
Neurological disorders
Dementia
57  Mild 0·047 (0·007-0·157)
58  Moderate 0·167 (0·077-0·300)
59  Severe 0·276 (0·191-0·378)
Headache
60  Migraine 0·416 (0·375-0·457)
61  Tension-type 0·153 (0·065-0·288)
62  Medication overuse 0·184 (0·093-0·314)
Multiple sclerosis
63  Mild 0·129 (0·048-0·266)
64  Moderate 0·389 (0·340-0·442)
65  Severe 0·661 (0·586-0·731)
Epilepsy
66  Severe (seizures >= once a month) 0·462 (0·441-0·481)
67  Less severe (seizures 1-11 per year) 0·415 (0·376-0·457)
Parkinson's disease
68  Mild 0·033 (0·003-0·129)
69  Moderate 0·318 (0·241-0·403)
70  Severe 0·475 (0·458-0·488)
Mental, behavioural, and substance use disorders
Alcohol use disorder
71  Very mild 0·060 (0·011-0·180)
72  Mild 0·144 (0·058-0·280)
73  Moderate 0·225 (0·133-0·344)
74  Severe 0·289 (0·202-0·386)
Fetal alcohol syndrome
75  Mild 0·028 (0·003-0·115)
76  Moderate 0·109 (0·036-0·245)
77  Severe 0·201 (0·109-0·326)
Cannabis dependence
78  Mild 0·38 (0·327-0·438)
79  Severe 0·597 (0·55-0·645)
Amphetamine dependence
80  Mild 0·318 (0·241-0·404)
81  Severe 0·622 (0·565-0·679)
Cocaine dependence
82  Mild 0·287 (0·205-0·385)
83  Severe 0·497 (0·486-0·506)
Heroin and other opioid dependence
84  Mild 0·494 (0·483-0·502)
85  Severe 0·752 (0·640-0·841)
Anxiety disorders
86  Mild 0·029 (0·003-0·118)
87  Moderate 0·115 (0·040-0·253)
88  Severe 0·556 (0·528-0·588)
Major depressive disorder
89  Mild episode 0·053 (0·009-0·168)
90  Moderate episode 0·509 (0·500-0·520)
91  Severe episode 0·699 (0·608-0·777)
Bipolar disorder
92  Manic episode 0·501 (0·492-0·510)
93  Residual state 0·060 (0·012-0·181)
Schizophrenia
94  Acute state 0·711 (0·616-0·797)
95  Residual state 0·590 (0·548-0·633)
96  Anorexia nervosa 0·093 (0·026-0·226)
97  Bulimia nervosa 0·070 (0·015-0·195)
98  Attention deficit hyperactivity disorder 0·028 (0·002-0·116)
99  Conduct disorder 0·241 (0·149-0·354)
100  Borderline intellectual functioning 0·015 (0·001-0·078)
Intellectual disability/mental retardation
101  Mild 0·075 (0·018-0·202)
102  Moderate 0·096 (0·028-0·229)
103  Severe 0·115 (0·039-0·252)
104  Profound 0·228 (0·136-0·348)
Hearing and vision loss
Hearing loss
105  Mild 0·031 (0·003-0·122)
106  Moderate 0·068 (0·014-0·192)
107  Severe 0·246 (0·156-0·358)
108  Profound 0·200 (0·109-0·327)
109  Complete 0·151 (0·065-0·287)
110  Mild, with ringing 0·042 (0·006-0·146)
111  Moderate, with ringing 0·076 (0·017-0·204)
112  Severe, with ringing 0·233 (0·140-0·351)
113  Profound, with ringing 0·183 (0·093-0·313)
114  Complete, with ringing 0·236 (0·145-0·353)
Distance vision
115  Mild impairment 0·009 (0·0003-0·057)
116  Moderate impairment 0·040 (0·005-0·144)
117  Severe impairment 0·219 (0·127-0·340)
118  Blindness 0·221 (0·129-0·341)
119  Monocular 0·052 (0·008-0·165)
120  Presbyopia 0·016 (0·001-0·081)
Musculoskeletal disorders
Low back pain
121  Mild 0·046 (0·007-0·156)
122  Moderate 0·115 (0·039-0·250)
123  Severe, without leg pain 0·164 (0·076-0·298)
124  Severe, with leg pain 0·180 (0·089-0·311)
125  Most severe, without leg pain 0·180 (0·090-0·312)
126  Most severe, with leg pain 0·188 (0·095-0·317)
Neck pain
127  Mild 0·047 (0·007-0·159)
128  Moderate 0·070 (0·015-0·196)
129  Severe 0·126 (0·045-0·263)
130  Most severe 0·106 (0·033-0·242)
Musculoskeletal problems
131  Legs, mild 0·043 (0·006-0·149)
132  Legs, moderate 0·122 (0·043-0·259)
133  Legs, severe 0·162 (0·073-0·294)
134  Arms, mild 0·047 (0·007-0·157)
135  Arms, moderate 0·123 (0·044-0·260)
136  Generalized, moderate 0·138 (0·055-0·275)
137  Generalized, severe 0·306 (0·228-0·396)
138  Gout, acute 0·212 (0·119-0·335)
Injury
139  Amputation of one upper limb (long term, without treatment) 0·117 (0·040-0·253)
140  Concussion (short term) 0·083 (0·021-0·213)
141  Spinal cord lesion, below neck level (treated) 0·359 (0·297-0·425)
Other
Abdominopelvic problem
142  Mild 0·039 (0·005-0·143)
143  Moderate 0·175 (0·084-0·307)
144  Severe 0·420 (0·382-0·459)
Anaemia
145  Mild 0·009 (0·0003-0·057)
146  Moderate 0·094 (0·026-0·226)
147  Severe 0·179 (0·088-0·310)
148 Periodontitis 0·019 (0·001-0·091)
149 Dental caries: symptomatic 0·018 (0·001-0·087)
150 Severe tooth loss 0·046 (0·007-0·156)
Disfigurement
151  Level 1 0·048 (0·007-0·159)
152  Level 2 0·154 (0·067-0·289)
153  Level 3 0·572 (0·537-0·608)
154  Level 1, with itch or pain 0·063 (0·013-0·186)
155  Level 2, with itch or pain 0·192 (0·100-0·321)
156  Level 3, with itch or pain 0·625 (0·567-0·683)
Generic uncomplicated disease
157  Worry and daily medication 0·045 (0·006-0·153)
158  Anxiety about diagnosis 0·018 (0·001-0·087)
159 Kwashiorkor 0·079 (0·019-0·207)
160 Severe wasting 0·154 (0·067-0·287)
161 Speech problems 0·041 (0·005-0·146)
Motor impairment
162  Mild 0·029 (0·003-0·119)
163  Moderate 0·044 (0·006-0·151)
164  Severe 0·262 (0·174-0·370)
Motor plus cognitive impairments
165  Mild 0·036 (0·004-0·135)
166  Moderate 0·075 (0·017-0·202)
167  Severe 0·271 (0·184-0·373)
168 Rectovaginal fistula 0·340 (0·271-0·416)
169 Vesicovaginal fistula 0·229 (0·136-0·347)
170 Thrombocytopenic purpura 0·131 (0·05-0·268)
171 Hypothyroidism 0·030 (0·003-0·120)
172 Hyperthyroidism 0·117 (0·040-0·253)
173 Neck pain, moderate 0·103 (0·032-0·240)
174 Osteomyelitis 0·107 (0·034-0·242)
175 Shoulder lesions 0·031 (0·003-0·123)
176 Heart burn & reflux “GERD” 0·092 (0·025-0·225)
177 Constipation 0·061 (0·012-0·181)
178 Vaginal discharge 0·028 (0·002-0·115)
179 Dyspareunia 0·044 (0·006-0·151)
180 Stress incontinence 0·046 (0·006-0·155)
181 Irritable bowel syndrome 0·045 (0·006-0·151)
182 Somatoform disorder 0·097 (0·028-0·231)
183 Borderline personality disorder 0·196 (0·103-0·322)
184 Harmful alcohol use 0·098 (0·029-0·233)
185 Vertigo and balance disorder (Menière, labyrinthitis) 0·065 (0·013-0·186)
186 Trigeminal neuralgia 0·088 (0·024-0·22)
187 Encephalopathy - moderate 0·175 (0·085-0·306)
188 Encephalopathy - severe 0·285 (0·200-0·383)
189 Thrombocytopenic purpura 0·141 (0·056-0·277)
190 Lymphogranuloma Venereum - local infection 0·104 (0·032-0·238)
191 Subacute sclerosing panencephalitis - phase 1 0·056 (0·010-0·173)
192 Subacute sclerosing panencephalitis - phase 2 0·151 (0·065-0·286)
194 Haemorrhoids 0·091 (0·025-0·224)
195 Anal fissure/abcess/fistula 0·069 (0·015-0·194)
196 Hyperthyroidism 0·073 (0·016-0·198)
197 Allergic rhinitis (hay fever) 0·015 (0·001-0·076)
198 Varicose veins 0·039 (0·005-0·141)
199 Carpal tunnel syndrome 0·028 (0·003-0·117)
200 Intensive care unit admission 0·669 (0·589-0·741)
201 Invasive device/drain 0·175 (0·084-0·307)
202 Insomnia 0·040 (0·005-0·144)
203 Sleep apnoea 0·080 (0·020-0·209)
204 Hypothyroidism 0·042 (0·006-0·146)
205 Hearing loss, moderate (Modified)* 0·068 (0·014-0·193)
206 Hearing loss, severe (Modified)* 0·222 (0·131-0·342)

Health state ‘Subacute sclerosing panencephalitis - phase 2’ numbered 193 was omitted in probit analysis due to its collinearity. Thus, we didn't report DW value of this health state finally. * We modified the two lay descriptions of moderate and severe hearing loss health states in our study.